141 related articles for article (PubMed ID: 34493474)
1. Loss of FANCD2 and related proteins may predict malignant transformation in oral epithelial dysplasia.
Ho MW; Ryan MP; Gupta J; Triantafyllou A; Risk JM; Shaw RJ; Wilson JB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Apr; 133(4):377-387. PubMed ID: 34493474
[TBL] [Abstract][Full Text] [Related]
2. The clinical determinants of malignant transformation in oral epithelial dysplasia.
Ho MW; Risk JM; Woolgar JA; Field EA; Field JK; Steele JC; Rajlawat BP; Triantafyllou A; Rogers SN; Lowe D; Shaw RJ
Oral Oncol; 2012 Oct; 48(10):969-976. PubMed ID: 22579265
[TBL] [Abstract][Full Text] [Related]
3. Oral Epithelial Dysplasia: A Review of Diagnostic Criteria for Anatomic Pathologists.
Cheung VKY; Hulme K; Schifter M; Palme C; Low TH; Clark J; Gupta R
Adv Anat Pathol; 2022 Jul; 29(4):227-240. PubMed ID: 35435865
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading.
Dost F; Lê Cao K; Ford PJ; Ades C; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):343-52. PubMed ID: 24388536
[TBL] [Abstract][Full Text] [Related]
5. Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models.
Mahmood H; Bradburn M; Rajpoot N; Islam NM; Kujan O; Khurram SA
Mod Pathol; 2022 Sep; 35(9):1151-1159. PubMed ID: 35361889
[TBL] [Abstract][Full Text] [Related]
6. Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
Ellis BG; Whitley CA; Triantafyllou A; Gunning PJ; Smith CI; Barrett SD; Gardner P; Shaw RJ; Weightman P; Risk JM
PLoS One; 2022; 17(3):e0266043. PubMed ID: 35333891
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia.
Mahmood H; Shephard A; Hankinson P; Bradburn M; Araujo ALD; Santos-Silva AR; Lopes MA; Vargas PA; McCombe KD; Craig SG; James J; Brooks J; Nankivell P; Mehanna H; Rajpoot N; Khurram SA
Br J Cancer; 2023 Nov; 129(10):1599-1607. PubMed ID: 37758836
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of oral epithelial dysplasia managed by observation versus excision.
Bernard C; Zhang JZ; Klieb H; Blanas N; Xu W; Magalhaes M
Head Neck; 2023 Dec; 45(12):3096-3106. PubMed ID: 37800675
[TBL] [Abstract][Full Text] [Related]
9. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
10. Characterization of initial/early histologic features of proliferative leukoplakia and correlation with malignant transformation: a multicenter study.
Alabdulaaly L; Villa A; Chen T; Kerr A; Ross N; Abreu Alves F; Guollo A; Woo SB
Mod Pathol; 2022 Aug; 35(8):1034-1044. PubMed ID: 35184151
[TBL] [Abstract][Full Text] [Related]
11. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
Müller S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of oral epithelial dysplasia in Southwest Finland.
Nevanpää TT; Terävä AE; Laine HK; Rautava J
Sci Rep; 2022 May; 12(1):8261. PubMed ID: 35585112
[TBL] [Abstract][Full Text] [Related]
13. A digital score of peri-epithelial lymphocytic activity predicts malignant transformation in oral epithelial dysplasia.
Bashir RMS; Shephard AJ; Mahmood H; Azarmehr N; Raza SEA; Khurram SA; Rajpoot NM
J Pathol; 2023 Aug; 260(4):431-442. PubMed ID: 37294162
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and immunoexpression of PTEN in oral epithelial dysplasia and squamous cell carcinoma.
Chaves FN; Bezerra TMM; Moraes DC; Costa SFDS; Silva PGB; Alves APNN; Costa FWG; Bernardes VF; Pereira KMA
Exp Mol Pathol; 2020 Feb; 112():104341. PubMed ID: 31730755
[TBL] [Abstract][Full Text] [Related]
16. An Update on the Use of Artificial Intelligence in Digital Pathology for Oral Epithelial Dysplasia Research.
Alajaji SA; Khoury ZH; Jessri M; Sciubba JJ; Sultan AS
Head Neck Pathol; 2024 May; 18(1):38. PubMed ID: 38727841
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
18. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
Reliene R; Yamamoto ML; Rao PN; Schiestl RH
Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
[TBL] [Abstract][Full Text] [Related]
19. Calibration improves the agreement in grading oral epithelial dysplasia-Findings from a National Workshop in Malaysia.
Kallarakkal TG; Zaini ZM; Ghani WMN; Karen-Ng LP; Siriwardena BSMS; Cheong SC; Tilakaratne WM
J Oral Pathol Med; 2024 Jan; 53(1):53-60. PubMed ID: 38081145
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
